BG105126A - Tetrahydronaphthyridinyl-carboxamides have anti-convulsant activity - Google Patents

Tetrahydronaphthyridinyl-carboxamides have anti-convulsant activity

Info

Publication number
BG105126A
BG105126A BG105126A BG10512601A BG105126A BG 105126 A BG105126 A BG 105126A BG 105126 A BG105126 A BG 105126A BG 10512601 A BG10512601 A BG 10512601A BG 105126 A BG105126 A BG 105126A
Authority
BG
Bulgaria
Prior art keywords
alkyl
hydrogen
groups
cycloalkyl
phenyl
Prior art date
Application number
BG105126A
Other languages
Bulgarian (bg)
English (en)
Inventor
John HARLING
Frank Harrington
Mervyn Thompson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BG105126A publication Critical patent/BG105126A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG105126A 1998-06-12 2001-01-08 Tetrahydronaphthyridinyl-carboxamides have anti-convulsant activity BG105126A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9812683.2A GB9812683D0 (en) 1998-06-12 1998-06-12 Novel compounds
PCT/GB1999/001826 WO1999065903A1 (en) 1998-06-12 1999-06-09 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity

Publications (1)

Publication Number Publication Date
BG105126A true BG105126A (en) 2001-11-30

Family

ID=10833636

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105126A BG105126A (en) 1998-06-12 2001-01-08 Tetrahydronaphthyridinyl-carboxamides have anti-convulsant activity

Country Status (31)

Country Link
US (2) US6410555B1 (de)
EP (1) EP1084122B1 (de)
JP (1) JP2002518390A (de)
KR (1) KR20010052792A (de)
CN (1) CN1311789A (de)
AP (1) AP2000002009A0 (de)
AR (1) AR018656A1 (de)
AT (1) ATE252579T1 (de)
AU (1) AU750470B2 (de)
BG (1) BG105126A (de)
BR (1) BR9911110A (de)
CA (1) CA2334900A1 (de)
CO (1) CO5040081A1 (de)
CZ (1) CZ293010B6 (de)
DE (1) DE69912278T2 (de)
EA (1) EA200100033A1 (de)
ES (1) ES2209524T3 (de)
GB (1) GB9812683D0 (de)
HU (1) HUP0102773A3 (de)
ID (1) ID27593A (de)
IL (1) IL140171A0 (de)
MA (1) MA26646A1 (de)
NO (1) NO20006269L (de)
NZ (1) NZ508799A (de)
PE (1) PE20000727A1 (de)
PL (1) PL344791A1 (de)
SK (1) SK18962000A3 (de)
TR (1) TR200003694T2 (de)
TW (1) TW495510B (de)
WO (1) WO1999065903A1 (de)
ZA (1) ZA200007397B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812683D0 (en) * 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds
ES2185606T3 (es) * 2001-03-21 2003-05-01 Sanol Arznei Schwarz Gmbh Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma.
CA2624625A1 (en) * 2005-11-04 2007-05-10 Pfizer Limited Tetrahydronaphthyridine derivative
TW201408658A (zh) * 2012-08-27 2014-03-01 Array Biopharma Inc 絲胺酸/酥胺酸激酶抑制劑

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
HUP9902166A3 (en) 1996-06-17 2001-01-29 Smithkline Beecham Plc Substituted benzamide derivatives having anticonvulsant activity, preparation and use thereof, pharmaceutical compositions containing these compounds
GB9711257D0 (en) 1997-05-30 1997-07-30 Smithkline Beecham Plc Novel compounds
GB9812683D0 (en) * 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
SK18962000A3 (sk) 2001-08-06
EA200100033A1 (ru) 2001-06-25
WO1999065903A1 (en) 1999-12-23
ES2209524T3 (es) 2004-06-16
NO20006269L (no) 2001-02-07
US6410555B1 (en) 2002-06-25
AR018656A1 (es) 2001-11-28
CZ20004611A3 (en) 2001-06-13
ZA200007397B (en) 2002-02-27
TR200003694T2 (tr) 2001-06-21
US6762192B2 (en) 2004-07-13
PE20000727A1 (es) 2000-09-28
CA2334900A1 (en) 1999-12-23
US20020143029A1 (en) 2002-10-03
ATE252579T1 (de) 2003-11-15
AP2000002009A0 (en) 2000-12-31
CO5040081A1 (es) 2001-05-29
DE69912278D1 (en) 2003-11-27
MA26646A1 (fr) 2004-12-20
NO20006269D0 (no) 2000-12-11
NZ508799A (en) 2003-08-29
HUP0102773A3 (en) 2002-09-30
DE69912278T2 (de) 2004-08-12
ID27593A (id) 2001-04-12
JP2002518390A (ja) 2002-06-25
CZ293010B6 (cs) 2004-01-14
EP1084122B1 (de) 2003-10-22
PL344791A1 (en) 2001-11-19
HUP0102773A2 (hu) 2002-01-28
IL140171A0 (en) 2002-02-10
TW495510B (en) 2002-07-21
BR9911110A (pt) 2001-10-30
GB9812683D0 (en) 1998-08-12
AU750470B2 (en) 2002-07-18
CN1311789A (zh) 2001-09-05
AU4280099A (en) 2000-01-05
KR20010052792A (ko) 2001-06-25
EP1084122A1 (de) 2001-03-21

Similar Documents

Publication Publication Date Title
EA200500018A1 (ru) Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения
EP1529047B8 (de) Neue purine derivate
NO994509D0 (no) Pyrrolo[2,3]pyrimidiner og deres anvendelse som tyrosinaseinhibitorer
MY139357A (en) Novel benzoimidazole derivatives useful as antiproliferative agents
MXPA06001274A (es) Compuestos novedosos que poseen actividad inhibitoria contra transporador dependiente de sodio.
PL141641B1 (en) Agent for fighting against and/or preventing paralyzing effects of microorganisms and method of obtaining new derivatives of n-/2-nitrophenylo/-4-aminopyrimidiines
ES2164920T3 (es) Nuevos derivados heterociclicos y uso medicinal de los mismos.
AR029343A1 (es) USO DE UN ANTAGONISTA DE NMDA DE BAJA AFINIDAD PARA EL TRATAMIENTO DE LA DEPRESIoN
GB2392156B (en) New purine derivatives
HRP20000508B1 (hr) Supstituirani 2-benzilamino-2-fenil-acetamidni spojevi
IL160874A0 (en) 4-imidazolin-2-one derivatives
BG105126A (en) Tetrahydronaphthyridinyl-carboxamides have anti-convulsant activity
PT1628968E (pt) Compostos de 4-imidazolin-2-ona
AP9901635A0 (en) Anti-convulsant isoquinolyl-benzamide derivatives.
CA2289638A1 (en) Fungicidal mixtures
MY106786A (en) Novel antiviral tetrahydroimidazo [1,4] benzodiazepin -2- (thi)ones
BR9809685B1 (pt) mistura fungicida, processo para controlar fungos nocivos, uso de um composto, e, composição.
AR029375A1 (es) DERIVADOS DE CARBOXAMIDA, UN PROCEDIMIENTO PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACEUTICA QUE LOS COMPRENDE Y EL USO DE DICHO DERIVADO PARA LA FABRICACION DE UN MEDICAMENTO
ES458548A1 (es) Procedimiento para la preparacion de derivados de benzamida.
ECSP993010A (es) Compuestos de formula (1) y sus sales y solvatos farmaceuticamente aceptables
NO940122L (no) Nye adenosinderivater